Ostrowski Erik

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ostrowski Erik's trades of Akebia Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
295.54
Quantity 31,119
Value US$701,740
Transaction date
Proposed sale
Price
1.39
Quantity 34,951
Value US$48,739
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-01 2026-06-29 S Sale
93,061 -40.3%
391.03
US$4,036,686
93,061 -40.3% 391.03 US$4,036,686
2026-06-29 2026-06-29 PrS Proposed sale
31,119
295.54
US$701,740
31,119 295.54 US$701,740
2026-02-04 2026-02-02 PlS Planned sale
19,453 -34.5%
493.53
US$3,482,828
19,453 -34.5% 493.53 US$3,482,828
2026-02-02 2026-02-02 PrS Proposed sale
34,951
1.39
US$48,739
34,951 1.39 US$48,739
2025-07-01 2025-06-30 PlS Planned sale
41,314 -7.6%
3.67
US$151,622
41,314 -7.6% 3.67 US$151,622